Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (231-240 of 611) with videos related to

Pageof 62
Sort By:
Revue Neurologique|January 1, 1985
[In vivo study of central serotoninergic receptors in man using positron tomography]J C Baron, Y Samson, D Comar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1987
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systemsM Ruberg, A Villageois, A M Bonnet, et al.
Journal of Neurochemistry|February 1, 1979
Post mortem stability and storage in the cold of brain enzymesJ Puymirat, F Javoy-Agid, P Gaspar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1989
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?B Pillon, B Dubois, G Cusimano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1982
Confusion, dementia and anticholinergics in Parkinson's diseaseY de Smet, M Ruberg, M Serdaru, et al.
Advances in Neurology|January 1, 1988
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystoniaM Ruberg, A Villageois, A M Bonnet, et al.
Neurology|March 1, 1997
Low-dose clozapine improves dyskinesias in Parkinson's diseaseF Durif, M Vidailhet, F Assal, et al.
Sbornik Lekarsky|February 28, 2001
The effects of apomorphine on attentional processing in Parkinson's diseaseE Růzicka, F el Massioui, B Pillon, et al.
European Neurology|June 23, 2005
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatmentD J Brooks, Y Agid, K Eggert, et al.
Annals of Neurology|June 1, 1990
Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?E C Hirsch, C Duyckaerts, F Javoy-Agid, et al.
Pageof 62

Showing results (231-240 of 611) with videos related to

Sort By:
Pageof 62
Revue Neurologique|January 1, 1985
[In vivo study of central serotoninergic receptors in man using positron tomography]J C Baron, Y Samson, D Comar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1987
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systemsM Ruberg, A Villageois, A M Bonnet, et al.
Journal of Neurochemistry|February 1, 1979
Post mortem stability and storage in the cold of brain enzymesJ Puymirat, F Javoy-Agid, P Gaspar, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1989
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?B Pillon, B Dubois, G Cusimano, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1982
Confusion, dementia and anticholinergics in Parkinson's diseaseY de Smet, M Ruberg, M Serdaru, et al.
Advances in Neurology|January 1, 1988
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystoniaM Ruberg, A Villageois, A M Bonnet, et al.
Neurology|March 1, 1997
Low-dose clozapine improves dyskinesias in Parkinson's diseaseF Durif, M Vidailhet, F Assal, et al.
Sbornik Lekarsky|February 28, 2001
The effects of apomorphine on attentional processing in Parkinson's diseaseE Růzicka, F el Massioui, B Pillon, et al.
European Neurology|June 23, 2005
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatmentD J Brooks, Y Agid, K Eggert, et al.
Annals of Neurology|June 1, 1990
Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?E C Hirsch, C Duyckaerts, F Javoy-Agid, et al.
Pageof 62